These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9713593

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
    Donato MF, Arosio E, Del Ninno E, Ronchi G, Lampertico P, Morabito A, Balestrieri MR, Colombo M.
    Hepatology; 2001 Sep; 34(3):523-8. PubMed ID: 11526538
    [Abstract] [Full Text] [Related]

  • 6. In hepatocellular carcinoma AgNOR protein expression correlates with tumour mass doubling time.
    Trerè D, Gramantieri L, Siringo S, Melchiorri C, Barbara L, Bolondi L, Derenzini M.
    J Hepatol; 1996 Jan; 24(1):60-5. PubMed ID: 8834026
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. AgNOR counts are not altered in alcoholic cirrhosis.
    Misra V, Misra SP, Dwivedi M, Gupta SC.
    Indian J Pathol Microbiol; 2003 Apr; 46(2):170-2. PubMed ID: 15022901
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis?
    Fracanzani AL, Borzio M, Roncalli M, Derenzini M, Trerè D, Mattioli M, Taioli E, Fiorelli G, Fargion S.
    Am J Gastroenterol; 2000 Oct; 95(10):2940-5. PubMed ID: 11051372
    [Abstract] [Full Text] [Related]

  • 14. Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.
    Mazzanti R, Messerini L, Comin CE, Fedeli L, Ganne-Carrie N, Beaugrand M.
    World J Gastroenterol; 2007 Oct 07; 13(37):5009-14. PubMed ID: 17854145
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.
    Sangiovanni A, Colombo E, Radaelli F, Bortoli A, Bovo G, Casiraghi MA, Ceriani R, Roffi L, Redaelli A, Rossini A, Spinzi G, Minoli G.
    Am J Gastroenterol; 2001 May 07; 96(5):1575-80. PubMed ID: 11374702
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection.
    Trerè D, Borzio M, Morabito A, Borzio F, Roncalli M, Derenzini M.
    Hepatology; 2003 Jan 07; 37(1):72-8. PubMed ID: 12500191
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.